Brad Hively
Chief Executive Officer at Starling Oncology Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Starling Oncology Inc., 3 years.
Starling Oncology Inc.
Director · Chief Executive Officer
Chief executive roles
Starling Oncology Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 21, 2026 | Starling Oncology Inc. | Open-market sale | −298,853 | $6.51 | $1,946,310 |
| Jul 27, 2026 | Starling Oncology Inc. | Grant or award | +27,108 | — | — |
| Dec 15, 2025 | Starling Oncology Inc. | Open-market sale | −13,333 | $3.77 | $50,265 |
| Nov 20, 2025 | Starling Oncology Inc. | Grant or award | +41,667 | — | — |
| Nov 20, 2025 | Starling Oncology Inc. | Grant or award | +32,407 | — | — |
| Aug 19, 2025 | Starling Oncology Inc. | Open-market sale | −20,221 | $4.06 | $82,097 |
| Jun 3, 2025 | Starling Oncology Inc. | Option exercise | +684,528 | $0.85 | $581,849 |
| Jun 3, 2025 | Starling Oncology Inc. | Option exercise | +105,320 | $0.48 | $50,554 |
| Jun 3, 2025 | Starling Oncology Inc. | Option exercise | +131,297 | $1.87 | $245,525 |
| Jun 3, 2025 | Starling Oncology Inc. | Option exercise | +946,460 | $0.85 | $804,491 |
| Jun 3, 2025 | Starling Oncology Inc. | Open-market sale | −1,867,605 | $2.87 | $5,360,026 |
| Jun 3, 2025 | Starling Oncology Inc. | Open-market sale | −108,532 | $2.87 | $311,487 |
| Mar 26, 2025 | Starling Oncology Inc. | Open-market purchase | +9,056 | $1.04 | $9,418 |
| Dec 2, 2024 | Starling Oncology Inc. | Open-market purchase | +50,000 | $0.15 | $7,500 |
| Nov 26, 2024 | Starling Oncology Inc. | Open-market purchase | +250,000 | $0.17 | $42,500 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.